052IC - Renal Mass and Localized Renal Cancer: Evaluation, Management and Follow-Up - A Case-Based Approach

· The AUA Guidelines for Localized Renal Cancer have been revised (2021) and are now available at https://www.auanet.org/guidelines/guidelines/renal-mass-and-localized-renal-cancer-evaluation-management-and-follow-up. This revision has been extensive and integrates the 2 previous guidelines for localized kidney cancer. An evidence-based approach was prioritized with focus on providing guidance for urologists in routine clinical practice. The revisions include:
· Apply the AUA Guidelines regarding the evaluation, management, and follow-up of patients with localized renal masses safely and effectively.
· Surgically manage challenging kidney cancer cases to prevent complications and optimize functional and oncologic outcomes.
· Evaluate, diagnose, and risk stratify patients with localized renal masses.
· Counsel patients with localized renal masses about the various management strategies, including oncologic and functional considerations and potential morbidities.
· Manage patients with localized renal masses, including appropriate and safe utilization of PN, RN, ablation and active surveillance.
· Employ surveillance for patients after intervention in a rational risk-based manner to optimize long-term outcomes.
· Advise patients regarding genetic counseling selectively to identify familial cases and to optimize outcomes for such patients and their families.

Agenda

Welcome and Introduction, Steven C. Campbell, MD, PhD

Chris Weight, MD
“Evaluation/Diagnosis (including Renal Mass Biopsy) and Follow-up after Intervention”

Steven C. Campbell, MD, PhD
“Counseling, PN and RN, and Functional Outcomes”

Philip M. Pierorazio, MD
“Thermal Ablation and Morbidities of all Strategies”

Robert G. Uzzo MD
“Active Surveillance, Oncologic Outcomes of all Strategies, and Adjuvant Considerations”

00 PM “Questions and Answers”
Drs. Campbell, Pierorazio, Uzzo, and Weight